Objective To investigate the effects of Qili-Qiangxin capsule on cardiac and pulmonary functions in heart failure patients with chronic pulmonary heart disease. Methods A total of 64 heart failure patients with chronic pulmonary heart disease were divided into two groups with the method of random sampling: a treatment group (33 patients) and a control group (31 patients). The patients in the control group received conventional treatment, those in the control group received Qili-Qiangxin capsule on this basis the treatment group for 7 days. The changes of the cardiac and pulmonary functions, and plasma N-terminal pro B-type natriuretic peptide (NT-proBNP) were compared between two groups. Results The total effective rate in the treatment group was significantly higher than that of the control group (90.90% vs. 77.42%; χ2=3.908, P<0.05). There were significant difference between two groups in left ventricular ejection fraction (50.73% ± 7.23%vs. 45.22%± 6.36%;t=3.229, P=0.002), stroke volume (63.64 ± 8.38 ml vs. 56.73 ± 8.15 ml;t=3.341, P=0.001), right ventricular end-diastolic diameter (48.39 ±5.56 mm vs. 52.61 ± 6.95 mm; t=2.690, P=0.009), mean pulmonary arterial pressure (21.73 ± 5.78 mmHg vs. 27.26 ± 6.16 mmHg; t=3.705, P=0.001), plasma NT-proBNP level (535.73 ± 175.78 pg/ml vs. 831.26 ± 228.26 pg/ml; t=5.824, P=0.000), forced expiratory volume in first second (60.32% ± 5.56% vs. 48.61% ± 4.67%; t=9.093, P=0.000), percentage of forced expiratory volume in first second to forced vital capacity (66.73%± 5.78%vs. 58.26%± 5.34%;t=6.078, P=0.000), arterial oxygen saturation (96.73%± 5.78%vs. 93.26%± 5.26%;t=2.507, P=0.015), arterial partial pressure of oxygen (82.73 ± 16.78 mmHg vs. 67.26 ± 13.26 mmHg;t=4.075, P=0.000) arterial partial pressure of carbon dioxide (46.73 ± 8.78 mmHg vs. 54.26 ± 9.26 mmHg; t=3.339, P=0.00). Conclusion Qili-Qiangxin capsule can improve cardiac and pulmonary functions in heart failure patients with chronic pulmonary heart disease.

Objective? To explore the roles of continuous care of medical treatment and maintenance combination in transforming the lifestyles in elderly patients with lung cancer. Methods? Totally 182 elderly patients who were discharged from the Department of Integrated Chinese and Western Medicine, Xinxiang Central Hospital and received continuous care in communities from January 2017 to November 2018 were selected and divided into experimental (n=91) and control (n=91) groups according to the random number table. Patients in the control group received conventional continuous care after discharge, while patients in the experimental group received continuous care of medical treatment and maintenance combination. The Exercise of Self-Care Agency (ESCA) and Health Promoting Lifestyle Profile II (HPLP Ⅱ) were employed to compare the self-care agency and lifestyle between the two groups before and after intervention. Results? After intervention, the total ESCA score and scores of its various dimensions in the experimental group were higher than those in the control group;the scores of HPLPⅡ various dimensions in the experimental group were higher than those in the control group, and there were statistically significant differences between the two groups (P＜ 0.05). Conclusions? The continuous care combining medical treatment and endowment can improve the self-care agency and help to transform the lifestyle of elderly patients with lung cancer.